Invenshure launches oncology focused biotech company, eyes $30 million funding round
June 14, 2022 at 16:28 PM EDT
In the weeks ahead, Invenshure will also launch a round of funding which MEKanistic will use to begin Phase 1 clinical trials early next year.
